Skip to content

Scapular and Upper Limb Proprioceptive Neuromuscular Facilitation Techniques in Stroke With Scapular Dyskinesia.

Effects of Scapular and Upper Limb Proprioceptive Neuromuscular Facilitation Techniques on Shoulder Pain, Upper Limb Function & Gait in Stroke With Scapular Dyskinesia.

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07148466
Enrollment
44
Registered
2025-08-29
Start date
2025-08-19
Completion date
2026-02-21
Last updated
2025-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scapular Dyskinesis

Keywords

scapular PNF coupled with upper limb PNF

Brief summary

This study aims to fill this gap by investigating the effects of scapular and upper limb proprioceptive neuromuscular facilitation techniques on shoulder pain, upper limb function & gait in stroke with scapular dyskinesia. This study is a randomized control trial that includes 44 patients which were randomly divided into two groups each containing 22 participants. Experimental group will receive scapular PNF coupled with upper limb PNF and conventional physiotherapy treatment and Control group will receive only Conventional treatment.

Detailed description

Stroke is one of the major causes of disability, cognitive decline, and mortality worldwide. This condition is recognized as the second leading cause of disability and the third leading cause of death. Scapular dyskinesia (SD) refers to the abnormal movement and function of scapula .Changes in scapular kinematics can result from altered scapular recruitment patterns , muscles performance issues and flexibility deficits in the surrounding soft tissues which may restrict normal scapular movements during daily activities. Physical therapy is crucial for rehabilitating scapular disorders. The goal of therapeutic intervention is to restore the normal position, movement, and strength of the scapula. Specific exercises are designed to target the scapular stabilizing muscles. Proprioceptive Neuromuscular Facilitation (PNF) is a neurological technique used in therapeutic exercise that integrates functionally based diagonal movement patterns with neuromuscular facilitation techniques. This approach aims to elicit motor responses and enhance neuromuscular control and performance. This study aims to fill this gap by investigating the effects of scapular and upper limb proprioceptive neuromuscular facilitation techniques on shoulder pain, upper limb function & gait in stroke with scapular dyskinesia.

Interventions

scapular PNF coupled with upper limb PNF and conventional physiotherapy treatment . It was a 6 week's intervention in which patients got treatment protocol for 30 mints 5 times a week.

OTHERConventional treatment

Conventional treatment. It includes closed kinematic chain exercises of upper limb, upper and lower extremity range of motion exercises, stretching and strengthening exercises for upper limb, trunk and lower limb, balance & coordination, manual dexterity exercises (e.g., grasp release), and teaching of ADLs.. It was a 6 week's intervention in which patients got treatment protocol for 30 mints 5 times a week.

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* • Sub-acute * MCA * Age bracket 40-65 years. * Gender Male or Female. * Gait baseline score (DGI less than 19) * Patients with spasticity between grades (+1 and 1) on the Modified Ashworth Scale (MAS).

Exclusion criteria

* • Inability to communicate/understand instructions. * Stroke with other neurological conditions. * Patient with any other psychological and medical condition.

Design outcomes

Primary

MeasureTime frameDescription
Fugl-Meyer Assessment of Upper Extremity (FMA-UE)6 weeksAfter a stroke, the FMA-UE is frequently used to evaluate and track recovery in hemiplegic patients.. It is a specific tool for quantifying upper limb impairment and rehabilitation outcomes in stroke patients with hemiparesis. Using a 3-point ordinal scale, the assessment rates the patient's ability to complete each task: 0 denotes incapacity to execute, 1 denotes partial completion, and 2 denotes full performance. All item scores, which range from 0 to 126, are added up to determine the final score.
Dynamic gait index (DGI)6 weeksA participant's ability to maintain walking balance while adjusting to different task demands and dynamic situations is evaluated by the Dynamic Gait Index (DGI). It is especially helpful for people who have balance and vestibular problems, as well as those who are at risk of falling. Every item has a rating between 0 and 3, where 0 denotes significant impairment and 3 denotes normal performance. 24 is the maximum possible score. A total score of less than 19 out of 24 indicates that older adults are more likely to fall, whereas a score of more than 22 indicates safe walking.
Visual Analogue Scale6 weeksHayes and Patterson employed the visual analog scale (VAS), a pain rating tool, for the first time in 1921. A single handwritten mark is placed at one point along a 10-cm line that represents a continuum between the two ends of the scale, with no pain at the left end (0 cm) and the worst pain at the right end (10 cm). Self-identified evaluations of symptoms are used to calculate scores. The patient's discomfort is calculated by measuring the distance in centimeters between the patient's marks and the scale's beginning point (left end). The figures can be used to gauge a patient's pain progression or to compare pain across people with comparable diseases. 0 No pain, 1-3 slight pain, 4-6 moderate pain, and 7-10 excruciating pain.
10-Meter Walk Test (10MWT)6 weeksThe test calculates walking speed over a brief distance in meters per second. To the closest tenth of a second, the total time spent walking six meters (m) is recorded. Then, 6 meters is divided by the whole time (in seconds) to convert this distance to m/s. The following categories apply to walking speeds: Family Ambulatory \<0.40 m/s; Community Ambulator ≥0.80 m/s; Limited Community Ambulator 0.40 to \<0.80 m/s

Countries

Pakistan

Contacts

Primary ContactMahat zafar, MSNMPT
mahat.zafar@riphah.edu.pk03326624087

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026